share_log

HC Wainwright & Co. Initiates Coverage On OKYO Pharma With Buy Rating, Announces Price Target of $4

Benzinga ·  Nov 2, 2023 07:07

HC Wainwright & Co. analyst Yi Chen initiates coverage on OKYO Pharma (NASDAQ:OKYO) with a Buy rating and announces Price Target of $4.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment